Literature DB >> 22910554

The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells.

Hana Vakili1, Peter A Cattini.   

Abstract

Growth hormone (GH) is a prominent metabolic factor that is targeted by glucocorticoids; however, their role in GH production remains controversial. This is explained in part by discrepancies between in vitro and in vivo, short-term versus long-term exposure and even species-specific effects. The prevailing view, however, is that glucocorticoids are negative modulators of growth and GH production. An examination of recent findings from elegant avian and gene ablation in mice studies as well as clinical case reports, suggests this is not the case. The evidence suggests that the effect of glucocorticoids on growth and GH production can be uncoupled, and reveals they play a crucial and positive role in maturation of functional somatotrophs, the GH-producing cells of the anterior pituitary. Here, we provide an overview and insights into the possible roles of glucocorticoids in the development of somatotrophs before birth as well as regulation of GH production in infancy (neonatal) and adulthood (postnatal). A fully functional glucocorticoid-signaling pathway appears to be required for establishment of somatotrophs before birth, and glucocorticoids continue to be required for maintenance of GH production in the newborn. There is evidence to suggest progenitor somatotrophs may persist after birth, and perhaps account for the ability of glucocorticoid therapy to correct some cases of GH deficiency as a result of compromised glucocorticoid signaling. Finally, there is support for positive regulation of avian, murine and human GH gene activation and/or expression by glucocorticoids, however, there appears to be no common mechanism and the contribution of direct versus indirect effects remains unclear. Thus, our observations reveal a largely hidden face of glucocorticoids, specifically, a positive role in somatotroph development and GH gene activation/expression, which may enable us to better understand the differential effect of glucocorticoids on growth and GH production in human studies.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22910554     DOI: 10.1016/j.mce.2012.08.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

2.  Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect.

Authors:  Andrea Giustina; Gherardo Mazziotti
Journal:  Endocrine       Date:  2014-05-06       Impact factor: 3.633

3.  Pre- and Postnatal Effects of Corticosterone on Fitness-Related Traits and the Timing of Endogenous Corticosterone Production in a Songbird.

Authors:  Meghan S Strange; Rachel M Bowden; Charles F Thompson; Scott K Sakaluk
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2016-06-09

4.  Effects of HIP in protection of HSP70 for stress-induced cardiomyocytes injury and its glucorticoid receptor pathway.

Authors:  Zhang ZhiQing; Wang XinXing; Gong Jingbo; Zhan Rui; Gao Xiujie; Zhao Yun; Wu Lei; Leng Xue; Qian LingJia
Journal:  Cell Stress Chaperones       Date:  2014-05-01       Impact factor: 3.667

Review 5.  Glucocorticoids and the regulation of growth hormone secretion.

Authors:  Gherardo Mazziotti; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

6.  Expression of Rasd1 in mouse endocrine pituitary cells and its response to dexamethasone.

Authors:  Chad D Foradori; Laci Mackay; Chen-Che J Huang; Robert J Kemppainen
Journal:  Stress       Date:  2021-04-10       Impact factor: 3.340

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.